{"name":"Bin Lu","slug":"bin-lu","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Henagliflozin Proline Tablets treatment","genericName":"Henagliflozin Proline Tablets treatment","slug":"henagliflozin-proline-tablets-treatment","indication":"Other","status":"marketed"}]}],"pipeline":[{"name":"Henagliflozin Proline Tablets treatment","genericName":"Henagliflozin Proline Tablets treatment","slug":"henagliflozin-proline-tablets-treatment","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE9ELWFmT3lvSW8wLWlrNWJ4b0xuM1AwbjdnYTB6MEI2SVVodlNyR05QbEM4bkZaUnNvZTdwZW9xcnVXMUdHTmRhUktJTGlub0NLazQ3S1NGM182Zm1CM2Jj?oc=5","date":"2019-03-07","type":"trial","source":"nature.com","summary":"Emergence of new antigenic epitopes in the glycoproteins of human respiratory syncytial virus collected from a US surveillance study, 2015–17 - nature.com","headline":"Emergence of new antigenic epitopes in the glycoproteins of human respiratory syncytial virus collected from a US survei","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibEFVX3lxTE1yczZ1YmVhcVBuTjAwUmh2TUQ4OXNaMlc1RjFyWU5OSm5uQWJPWWF2VGpmeko3R2F1M2ltQ0NIam44VUxESnhwZXlWLUdsZ1hsaFp6Ukh2dFRXa0FKVUVIWGZEWjgwa3BBSjlycA?oc=5","date":"2017-09-02","type":"pipeline","source":"ARVO Journals","summary":"Translational development of human retinal progenitor cells for treatment of retinitis pigmentosa - ARVO Journals","headline":"Translational development of human retinal progenitor cells for treatment of retinitis pigmentosa","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxPSU9SamhFb0RaS19SODVlYzA0d011Z2lGX3Y4X3haRU14M2JJUFlYQ1VueG1IUGVlaG1VOUZuZzVRRC1vLVNaZTNBeWlfamZBRXNoZHhPTlZES2lTdXZXSDRvdzloRlE2eko4Wjlyd1Q1cVRVVmFBcEdmc19TSjBEbVZCYkZGQmhSWllaWllNbXUxZXhxb2c1NndBZVNSNlhHY09HdGpCTFpUX3pvRGEyN2pR?oc=5","date":"2014-04-18","type":"pipeline","source":"The Guardian","summary":"Global warming can't be blamed on CFCs – another one bites the dust - The Guardian","headline":"Global warming can't be blamed on CFCs – another one bites the dust","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}